The roles of catecholamines in glucoregulation in intense exercise as defined by the islet cell clamp technique

Diabetes

Volumn 45, Issue 2, 1996, Pages 148-156

  Sigal, Ronald J ^a   Fisher, Simon ^b   Halter, Jeffrey B ^c   Vranic, Mladen ^b   Marliss, Errol B ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON; INSULIN; NORADRENALIN; OCTREOTIDE;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLAMP; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

EID: 0030041557     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.2.148     Document Type: Article

References (35)

1. Vranic M, Wasserman DH, Bukowiecki L: Metabolic implications of exercise and physical fitness in physiology and diabetes. In Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice 4th ed. Rifkin H, Porte D, Eds. New York, Elsevier, 1990, p. 1908-1919
2. Calles J, Cunningham JJ, Nelson L, Brown N, Nadel E: Glucose turnover during recovery from intensive exercise. Diabetes 32:734-738, 1983
3. Kjaer M, Farrell PA, Christensen NJ, Galbo H: Increased epinephrine response and inaccurate glucoregulation in exercising athletes. J Appl Physiol 61:1693-1700, 1986
4. Marliss EB, Simantirakis E, Miles PDG, Purdon C, Gougeon-Reyburn R, Field CJ, Halter JB, Vranic M: Glucoregulatory and hormonal responses to repeated bouts of intense exercise in normal male subjects. J Appl Physiol 71:924-933, 1991
5. Marliss EB, Simantirakis E, Miles PDG, Hunt R, Gougeon-Reyburn R, Purdon C, Halter JB, Vranic M: Glucose turnover and its regulation during intense exercise and recoveiy in normal male subjects. Clin Invest Med 15:406-419, 1992
6. Marliss EB, Purdon C, Miles PDG, Halter JB, Sigal RJ, Vranic M: Glucoregulation during and after intense exercise in control and diabetic subjects. In Diabetes Mellitus and Exercise. Devlin J, Horton ES, Vranic M, Eds. London, Smith-Gordon, 1992, p. 173-190
7. Purdon C, Brousson M, Nyveen SL, Miles PDG, Halter JB, Vranic M, Marliss EB: The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects. J Clin Endocrinol Metab 76:566-573, 1993
8. Sigal RJ, Purdon C, Bilinski D, Vranic M, Halter JB, Marliss EB: Glucoregulation during and after intense exercise: effects of β-blockade. J Clin Endocrinol Metab 78:359-366, 1994
9. Wasserman DH, Lickley HLA, Vranic M: Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs. J Clin Invest 74:1404-1413, 1984
10. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharmacol 8:255-273, 1989
11. Krentz AJ, Boyle PJ, MacDonald LM, Schade DS: Octreotide, a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations Metabolism 43:24-31, 1994
12. a) during intense exercise, definition using the islet-cell clamp (IC) (Abstract). Diabetes 43 (Suppl. 1):159A, 1994
13. Finegood DT, Miles PDG, Lickley L, Vranic M: Estimation of glucose production with a one-compartment, variable-volume model of glucose kinetics. J Appl Physiol 72:2501-2509, 1992
14. Hirsch IB, Marker JC, Smith LJ, Spina RJ, Parvin CA, Holloszy JO, Cryer PE: Insulin and glucagon in prevention of hypoglycemia during exercise in humans. Am J Physiol 260:E695-E704, 1991
15. Marker JC, Hirsch IB, Smith J, Parvin CA, Holloszy JO, Cryer PE: Catecholamines in prevention of hypoglycemia during exercise in humans. Am J Physiol 260:E705-E712, 1991
16. Evans MI, Halter JB, Porte DJ: Comparison of double- and single-isotope enzymatic derivative methods for measuring catecholamines in plasma. Clin Chem 28:764-770, 1978
17. Radziuk J, Norwich KM, Vranic M: Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol 234:E84-E93, 1978
18. Bradley DC, Steil GM, Bergman RN: Quantitation of measurement error with optimal segments, basis for adaptive time course smoothing. Am J Physiol 264:E902-E911, 1993
19. Clutter WE, Rizza RA, Gerich JE, Cryer PE: Regulation of glucose metabolism by synpathochromaffin catecholamines. Diabetes Metab Rev 4:1-15, 1988
20. Wasserman DH, Spalding JA, Bracy D, Lacy DB, Cherrington AD: Exercise-induced rise in glucagon and ketogenesis during prolonged muscular work. Diabetes 38:799-807, 1989
21. Adkins-Marshall BA, Myers SR, Hendrick GK, Williams PE, Triebwasser K, Floyd B, Cherrington AD: Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes 39:87-95, 1990
22. Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE: Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. J Clin Invest 75:1842-1851, 1985
23. DeFeo P, Perriello G, Ventura MM, Brunetti P, Santeusanio F, Gerich JE, Bolli GB: The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans. Am J Physiol 252:E565-E570, 1987
24. Pless J, Bauer W, Briner U, Doepfner W, Marbach P, Maurer R, Petcher TJ, Reubi JC, Vonderscher J; Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin Scand J Gastroenterol 21 (Suppl. 119):54-64, 1986
25. Sigal RJ, Purdon C, Fisher S, Bilinski D, Halter JB, Vranic M, Marliss EB: Hyperinsulinemia prevents prolonged hyperglycemia following intense exercise in insulin-dependent diabetic subjects. J Clin Endocrinol Metab 79:1049-1057, 1994
26. Wade EE, Freund BJ: Hormonal control of blood volume during and following exercise. In Fluid Homeostasis During Exercise. Gisolfi CV, Lamb DR, Eds. Carmel, IN, Benchmark, 1990, p. 207-245
27. Cooper AM, Braatvedt GD, Halliweel M, Read AE, Corrall RJM Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci 81:169-175, 1991
28. Marbach P, Neufeld M: Clinical applications of somatostatin analogs Adv Exp Med Biol 188:339-353, 1985
29. Wasserman DH, Lacy DB, Bracy DP: Relationship between arterial and portal vein immunoreactive glucagon during exercise. J Appl Physiol 75:724-729, 1993
30. Kjaer M, Kiens B, Hargreaves M, Richter EA: Influence of active muscle mass on glucose homeostasis during exercise in humans. J Appl Physiol 71:552-557, 1991
31. Kjaer M, Engfred K, Fernandes A, Secher NH, Galbo H: Regulation of hepatic glucose production during exercise in humans: role of sympathoadrenergic activity. Am J Physiol 265:E275-E283, 1993
32. Wasserman DH, Williams PE, Brooks Lacy D, Bracy D, Cherrington AD Hepatic nerves are not essential to the increase in hepatic glucose production during muscular work. Am J Physiol 259:E195-E203, 1990
33. Kjaer M, Keiding S, Engfred K, Rasmussen K, Sonne B, Kerkegǎrd P, Galbo H: Glucose homeostasis during exercise in humans with a liver or kidney transplant. Am J Physiol 268:E636-E644, 1995
34. Bjorkman O: Fuel metabolism during exercise in normal and diabetic man. Diabetes Metab Rev 1:319-408, 1986
35. Coggan AB, Reguso CA, Williams BN, Gastaldelli A, Wolfe RR: Regulation of hepatic glucose production during high intensity exercise (Abstract). FASEB J 8:A669, 1994